ANBIO BIOTECHNOLOGY LTD (NNNN) Stock Cash Flow
USA - NASDAQ:NNNN - KYG0367B1059 - Common Stock
35.2 USD
-2.58 (-6.83%)
33.5 USD
-1.7 (-4.83%)
| TTM (2024-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 4.33M | 2.37M | 2.25M | 10.01M | 2.54M | |||
| Depreciation Amortization | N/A | N/A | 12.10K | 6.30K | 0.00 | |||
| Change In Working Capital | -4.68M | 44.70K | -1.20M | -5.53M | 1.65M | |||
| Other non cash items | N/A | -337.10K | -163.40K | -38.90K | N/A | |||
| OPERATING CASH FLOW | -650.40K | 2.08M | 898.40K | 4.45M | 4.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | 301.60K | 337.10K | 1.73M | -1.53M | 0.00 | |||
| INVESTING CASH FLOW | 301.60K | 337.10K | 1.73M | -1.53M | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Other Financing Activity | 98.10K | -344.60K | -42.80K | 0.00 | N/A | |||
| FINANCING CASH FLOW | 98.10K | -344.60K | -42.80K | 0.00 | N/A | |||
| CHANGE IN CASH | -250.80K | 2.07M | 2.59M | 2.92M | 4.18M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -650.40K | 2.08M | 898.40K | 4.45M | 4.18M | |||
| FREE CASH FLOW | -650.40K | 2.08M | 898.40K | 4.45M | 4.18M | |||
All data in USD